Abdominal and iliac arterial stenoses: comparative double-blinded randomized study of diagnostic accuracy of 3D MR angiography with gadodiamide or gadopentetate dimeglumine

Autor: Thomas Jahnke, Richard Coulden, P.J. Schaefer, Hans B. Gehl, Montserrat Bret-Zurita, Joerg W. Oestmann, Ramiro Méndez, Armin Huber, F. Boudghene, Dominik Weishaupt, Michel Nonent, Renate Hammerstingl, José Luis Caniego, Jesus C. Pueyo, Siegfried Thurnher, H J Brambs
Přispěvatelé: Department of Diagnostic Radiology, University Hospital of Schleswig-Holstein, Département de radiologie [Brest] (DR - Brest), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO)
Rok vydání: 2006
Předmět:
Gadolinium DTPA
Male
Contrast Media
MESH: Magnetic Resonance Angiography
030218 nuclear medicine & medical imaging
0302 clinical medicine
MESH: Aged
80 and over

Abdomen
MESH: Double-Blind Method
Prospective Studies
Prospective cohort study
MESH: Aged
Aged
80 and over

MESH: Middle Aged
MESH: Arterial Occlusive Diseases
medicine.diagnostic_test
MESH: Iliac Artery
Middle Aged
MESH: Predictive Value of Tests
3. Good health
medicine.anatomical_structure
030220 oncology & carcinogenesis
Predictive value of tests
Female
Radiology
medicine.drug
Adult
medicine.medical_specialty
MESH: Gadolinium DTPA
Arterial Occlusive Diseases
MESH: Imaging
Three-Dimensional

MESH: Abdomen
Iliac Artery
Sensitivity and Specificity
03 medical and health sciences
Imaging
Three-Dimensional

Double-Blind Method
Predictive Value of Tests
MESH: Contrast Media
medicine
Humans
Radiology
Nuclear Medicine and imaging

MESH: Angiography
Digital Subtraction

Aged
MESH: Humans
business.industry
Gadodiamide
Angiography
Digital Subtraction

Magnetic resonance imaging
MESH: Adult
medicine.disease
MESH: Male
MESH: Prospective Studies
MESH: Sensitivity and Specificity
Clinical trial
Stenosis
Angiography
business
Nuclear medicine
MESH: Female
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Magnetic Resonance Angiography
Zdroj: Radiology
Radiology, Radiological Society of North America, 2006, 238 (3), pp.827-40. ⟨10.1148/radiol.2383041769⟩
ISSN: 0033-8419
1527-1315
Popis: International audience; PURPOSE: To prospectively evaluate accuracy of gadolinium-enhanced three-dimensional (3D) magnetic resonance (MR) angiography with gadodiamide and gadopentetate dimeglumine (0.1 mmol/kg), with intraarterial DSA as reference standard, for imaging abdominal and iliac arterial stenoses. MATERIALS AND METHODS: The study was approved by all institutional review boards; informed consent was obtained from each subject before procedures. Two hundred forty-seven subjects were included; 240 received either contrast agent and were available for safety analysis; 222 were available for accuracy analysis. Enhanced 3D MR angiography and DSA were performed; image data were evaluated in a double-blinded randomized study. Stenoses were classified as not relevant ( or =50%). For detection of main stenosis, accuracy with enhanced 3D MR angiography compared with that with DSA was determined. RESULTS: The difference in accuracy for imaging with gadodiamide and gadopentetate was 3.6%. Noninferiority was inferred because the lower bound of the exact two-sided 95% confidence interval was -10.1 and was above the noninferiority margin (-15%). Accuracy for detection of the main stenosis was low, 56.4% for gadodiamide and 52.8% for gadopentetate group. Subgroup analysis with exclusion of inferior mesenteric artery and internal iliac arteries and the most false-positive stenosis classifications yielded better results: 76.6% and 71.6%, respectively. Sensitivity, specificity, and negative and positive predictive values did not differ substantially between study groups. In the main analysis, values were 44%, 96%, 35%, and 97% for gadodiamide and 44%, 83%, 30%, and 90% for gadopentetate, respectively. In the subgroup analysis, values were 66%, 95%, 61%, and 96% for gadodiamide and 63%, 86%, 58%, and 88% for gadopentetate, respectively. CONCLUSION: Noninferiority of gadodiamide versus gadopentetate was verified based on the primary end point, which was accuracy for detection of the main stenosis with enhanced 3D MR angiography compared with DSA.
Databáze: OpenAIRE